Dionysia Papagiannopoulou Selected Research

Acute Erythroblastic Leukemia (Erythroleukemia)

7/2021

PTD-mediated delivery of α-globin chain into Κ-562 erythroleukemia cells and α-thalassemic (HBH) patients' RBCs ex vivo in the frame of Protein Replacement Therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dionysia Papagiannopoulou Research Topics

Disease

4	Neoplasms (Cancer) 05/2018 - 01/2016
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2019 - 04/2017
1	Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease) 01/2023
1	Acute Erythroblastic Leukemia (Erythroleukemia) 07/2021
1	Hemoglobinopathies 07/2021
1	Thalassemia 07/2021
1	Mitochondrial Diseases (Mitochondrial Disease) 12/2020
1	Cytochrome-c Oxidase Deficiency 12/2020
1	Inborn Genetic Diseases (Disease, Hereditary) 12/2020
1	Adenocarcinoma of Lung 05/2018
1	Adenocarcinoma 05/2018
1	Glioblastoma (Glioblastoma Multiforme) 01/2018

Drug/Important Bio-Agent (IBA)

3	LigandsIBA 05/2018 - 04/2017
2	Proteins (Proteins, Gene)FDA Link 07/2021 - 12/2020
2	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2019 - 04/2017
1	Amyloid (Amyloid Fibrils)IBA 01/2023
1	Prion ProteinsIBA 01/2023
1	FlavonoidsIBA 01/2023
1	hemoglobin Bart'sIBA 07/2021
1	GlobinsIBA 07/2021
1	CationsIBA 01/2018
1	Peptides (Polypeptides)IBA 04/2017
1	Diphosphonates (Bisphosphonates)IBA 01/2016

Therapy/Procedure

2	Therapeutics 07/2021 - 12/2020